The new technique, developed by the California Institute of Molecular Medicine, USA, involves the extraction of Kupffer's cells from patients.
Kupffer's cells are cultured in the laboratory
In the new technique, the cells are extracted by fine-needle biopsy and cultured in the laboratory.
According its developers, it will allow patients to be treated without problems of immunological compatibility. It could also help patients with alcoholic liver disease.
The developers have filed a notice of invention with the US Patent Office. They say that Kupffer's cells are major components of the hepatic sinusoid and actively participate in the maintenance of normal liver function.
Dr William Carter, head of Hemispherx Biopharma, the major corporate shareholder in the institute, said: "This proprietary propagation method for Kuppfer's cells may offer HCV sufferers and alcoholics with significant liver damage, a chance to substantially prolong their normal liver functions."
Report Copyright: Englemed Health News at http://www.internationalmedicalnews.com